About
Stefan Luzi joined Gilde Healthcare in 2015 and is a Partner in the Venture&Growth team, focusing on investments in biopharmaceuticals and therapeutics. He previously worked at Merck KGaA in its Global Business Intelligence and M Ventures divisions, holds degrees from ETH Zurich and the University of Cambridge, and completed a PhD at the MRC Laboratory of Molecular Biology in Cambridge.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- Gilde HealthcarePartnercurrent2017 — presentThe Randstad, Netherlands
- Gilde HealthcareAssociate2015 — 2017The Randstad, Netherlands
- Merck GroupGlobal Graduate Program2013 — 2015Frankfurt Area / Greater Boston Area / Amsterdam
- Novartis Venture FundsIntern2009Basel, Switzerland
Skills & more
Biotechnology52Molecular Biology43Drug Discovery22Lifesciences14Biochemistry21Synthetic Biology9Life Sciences37Pharmaceutical Industry19Intellectual Property6Technology Transfer8Protein Chemistry7Entrepreneurship7
+9 more
ChemistryCell BiologyGenomicsLaboratoryVenture CapitalCorporate Venture CapitalBusiness IntelligenceResearchStrategyFrom Stefan's professional profile.
Colleagues at Gilde Healthcare
Arthur Franken
General Partner at Gilde Healthcare
Besmire Ahmati
Senior Associate Investor Relations & Fundraising at Gilde Healthcare
Christiaan Sap
Operational Partner at Gilde Healthcare
Dirkjan Beugelsdijk
CFO at Gilde Healthcare
Edward Hanlon
Investment Director Venture&Growth at Gilde Healthcare
Edwin de Graaf
Managing Partner at Gilde Healthcare
Geoff Pardo
General Partner at Gilde Healthcare
Giel Modderman
Associate, Private Equity at Gilde Healthcare
Frequently asked questions
- Who is Stefan Luzi?
- Stefan Luzi joined Gilde Healthcare in 2015 and is a Partner in the Venture&Growth team, focusing on investments in biopharmaceuticals and therapeutics. He previously worked at Merck KGaA in its Global Business Intelligence and M Ventures divisions, holds degrees from ETH Zurich and the University of Cambridge, and completed a PhD at the MRC Laboratory of Molecular Biology in Cambridge.
- Where does Stefan Luzi work?
- Stefan Luzi is Partner Therapeutics, Venture&Growth at Gilde Healthcare.
- What does Stefan Luzi invest in?
- Stefan Luzi invests in Biotech.
- Where did Stefan Luzi go to school?
- Stefan Luzi studied at University of Cambridge (PhD, Molecular Biology); University of Cambridge (MPhil, Bioscience Enterprise (MBE)); ETH Zürich (MSc, Biotechnology).
Same school
Also attended University of Cambridge893
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
.png)
+ 887 more
Also attended ETH Zürich225
Bastian HasslingerInvestor at Index VenturesSteve VassalloInvestor at Foundation CapitalHelge DaebelPartner, Head of Water at Emerald Technology Ventures AgMaurin DaiInvestment Manager, Physical AI & Robotics at Emerald Technology Ventures AgChristoph FreiPartner, Head of Energy at Emerald Technology Ventures AgMax HeftiInvestment Director - Energy at Emerald Technology Ventures Ag
+ 219 more
Also attended National University of Singapore332
Justin HallPartner at Golden Gate VenturesMahati SridharPartner, Rise of the Rest at RevolutionCeline XiaoInvestor at DN CapitalSofia DahouneInvestor at DaphniYi Min LohInvestment Associate at Burda Principal InvestmentsSean LooInvestment Analyst at Burda Principal Investments
+ 326 more
Shared employers
Also worked at Gilde Healthcare15
Andrea van ElsasInvestor at Third Rock VenturesAnastasia BudinskayaInvestor at NFXPieter van der MeerManaging Partner at Gilde HealthcareArthur FrankenGeneral Partner at Gilde HealthcareGeoff PardoGeneral Partner at Gilde HealthcareJanke DittmerGeneral Partner at Gilde Healthcare
+ 9 more
Also worked at Merck Group13
NG Jaz LinnAssistant Manager at SGInnovateClemens HabigImpact Consultant at GreenTec Capital PartnersShelby NewsadPartner at CompoundFrederic WohlwendManaging Partner at Forestay CapitalJan AdamsPartner at Apollo Health VenturesJohn Ephraim TorresGlobal Venture Development Director at Arowana Partners
+ 7 more
Also worked at Novartis Venture Funds130
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 124 more